Cardiovascular System Practice Questions

Q: In which stage of red blood cell development does hemoglobin first appear?

Early normoblast. ### Explanation The correct answer is **Early normoblast** (also known as the Basophilic normoblast). **1. Why Early Normoblast is Correct:** During erythropoiesis, the **Early Normoblast** is the stage where the synthesis of hemoglobin begins. While the cell is characterized by intense cytoplasmic basophilia (due to an abundance of RNA and ribosomes), biochemical assays detect the **first appearance of hemoglobin** at this stage. However, the concentration is initially too low to change the cell's staining characteristics, which is why the cytoplasm remains blue. **2. Analysis of Incorrect Options:** * **Intermediate Normoblast (Polychromatic):** This is the stage where hemoglobin becomes **visually detectable** under a light microscope. The cytoplasm shows a "polychromatic" (mixed) appearance of pink (hemoglobin) and blue (RNA). It is not the stage of first appearance, but rather the stage of significant accumulation. * **Late Normoblast (Orthochromatic):** At this stage, hemoglobin synthesis is nearly complete, giving the cytoplasm a purely eosinophilic (pink) appearance. The nucleus becomes pyknotic and is eventually extruded. * **Reticulocyte:** These are immature RBCs that have already lost their nuclei but still contain residual ribosomal RNA. Hemoglobin is already present in high concentrations. **3. High-Yield Clinical Pearls for NEET-PG:** * **First visible hemoglobin:** Intermediate normoblast. * **First synthesis/appearance of hemoglobin:** Early normoblast. * **Nucleus extrusion:** Occurs at the transition from Late Normoblast to Reticulocyte. * **Reticulocyte count:** A key indicator of bone marrow erythropoietic activity (Normal: 0.5–2%). * **Erythropoietin:** Acts primarily on the CFU-E (Colony Forming Unit-Erythroid) to initiate the differentiation process.

Q: Which of the following is seen in second-degree AV block?

Change in morphology of ventricular complex. **Explanation:** In **Second-degree AV block**, some atrial impulses fail to conduct to the ventricles. This leads to "dropped beats," where a P wave is not followed by a QRS complex. **Why Option A is Correct:** In second-degree AV block (specifically Mobitz Type II), the block often occurs at or below the Bundle of His. When the impulse finally passes through the diseased conduction system or if an escape rhythm originates from a lower ventricular site, the **morphology of the ventricular complex (QRS)** often changes. It may become widened or distorted (e.g., Bundle Branch Block pattern), reflecting an abnormal pathway of ventricular depolarization. **Analysis of Incorrect Options:** * **B. Increased atrial rate compared to ventricular rate:** This is a characteristic of **Third-degree (Complete) AV block**, where the atria and ventricles beat independently (AV dissociation), and the atrial rate (SA node) is significantly faster than the intrinsic ventricular escape rate. * **C. Increase in cardiac output:** AV blocks generally **decrease** cardiac output because the dropped beats lead to a lower effective heart rate (bradycardia). * **D. Decrease in stroke volume:** Actually, due to the longer diastolic filling time associated with the pause (dropped beat), the **stroke volume usually increases** (Frank-Starling mechanism) to compensate for the decreased heart rate, although this is insufficient to maintain total cardiac output. **High-Yield Clinical Pearls for NEET-PG:** * **Mobitz Type I (Wenckebach):** Progressive PR interval lengthening until a QRS is dropped. Usually localized to the AV node. * **Mobitz Type II:** Constant PR interval with intermittent dropped QRS complexes. High risk of progressing to complete heart block; often requires a permanent pacemaker. * **Key Distinction:** If the PR interval is fixed, it’s Type II; if it’s variable, it’s Type I.

Q: Which of the following phases is absent in the action potential of pacemaker cells?

Phase 1. **Explanation:** The cardiac action potential differs significantly between **contractile cells** (ventricular myocytes) and **pacemaker cells** (SA and AV nodes). Pacemaker cells exhibit "slow response" action potentials characterized by automaticity and the absence of a plateau phase [1]. **Why Phase 1 is absent:** Phase 1 represents **early rapid repolarization**, which is caused by the transient outward flow of potassium ions ($I_{to}$) and the abrupt closure of fast sodium channels. In pacemaker cells, depolarization (Phase 0) is mediated by the slow influx of Calcium ($Ca^{2+}$) through L-type channels rather than fast Sodium ($Na^+$) channels [1], [2]. Because there is no rapid sodium spike or subsequent transient potassium efflux, **Phase 1 (and Phase 2/Plateau) is entirely absent.** [1] **Analysis of Incorrect Options:** * **Phase 0 (Depolarization):** Present. In pacemaker cells, this is "slow" and mediated by $Ca^{2+}$ influx (unlike the "fast" $Na^+$ influx in myocytes) [1], [2]. * **Phase 3 (Repolarization):** Present. This is caused by the efflux of $K^+$ ions through delayed rectifier potassium channels, returning the membrane to its most negative potential [1]. * **Phase 4 (Pacemaker Potential):** Present and critical. This is the spontaneous diastolic depolarization caused by the "funny current" ($I_f$) through HCN channels, $T$-type $Ca^{2+}$ channels, and reduced $K^+$ efflux [1]. This phase is responsible for **automaticity** [3]. **High-Yield NEET-PG Pearls:** * **SA Node** is the primary pacemaker because it has the steepest Phase 4 slope. * **Preload/Vagal tone** decreases the slope of Phase 4 (bradycardia), while **Sympathetic tone** increases it (tachycardia). * **Drugs:** Calcium channel blockers (Verapamil/Diltiazem) act on Phase 0 of the pacemaker cell [2], slowing the heart rate and conduction.

Q: Which peptide causes increased capillary permeability and edema?

Bradykinin. **Explanation:** **Correct Option: C (Bradykinin)** Bradykinin is a potent vasodilator and a key mediator of the inflammatory response. It acts primarily on **B2 receptors** to stimulate the release of nitric oxide and prostacyclin. Its primary effect on the microvasculature is the contraction of endothelial cells, which increases the size of intercellular junctions (pores). This leads to **increased capillary permeability**, allowing fluid and plasma proteins to leak into the interstitial space, resulting in **edema**. **Analysis of Incorrect Options:** * **A. Histamine:** While histamine also increases capillary permeability and causes edema, it is an **amine** (derived from the amino acid histidine), not a **peptide**. The question specifically asks for a peptide. * **B. Angiotensin II:** This is a potent **vasoconstrictor** peptide. It generally increases blood pressure and decreases capillary hydrostatic pressure through systemic effects, rather than increasing permeability. * **D. Renin:** Renin is an **enzyme** (protease) secreted by the juxtaglomerular cells of the kidney. It catalyzes the conversion of Angiotensinogen to Angiotensin I; it does not directly affect capillary permeability. **High-Yield Clinical Pearls for NEET-PG:** * **ACE Inhibitors & Cough:** ACE (Angiotensin-Converting Enzyme) is responsible for the breakdown of Bradykinin. ACE inhibitors lead to an accumulation of Bradykinin, which causes the classic side effects of **dry cough** and **angioedema**. * **Hereditary Angioedema:** This condition is caused by a deficiency of **C1 esterase inhibitor**, leading to overproduction of Bradykinin, resulting in episodes of severe swelling. * **Triple Response of Lewis:** Bradykinin and Histamine are both involved in the "Wheal" component of the triple response due to increased permeability.

Q: Cardiac output in L/min divided by heart rate equals:

Mean stroke volume. ### Explanation **1. Why the correct answer is right:** The relationship between Cardiac Output (CO), Heart Rate (HR), and Stroke Volume (SV) is defined by the fundamental physiological formula: **Cardiac Output (CO) = Heart Rate (HR) × Stroke Volume (SV)** By rearranging this formula to solve for Stroke Volume: **Stroke Volume = Cardiac Output / Heart Rate** Stroke volume is the volume of blood ejected by the left ventricle during a single contraction. When you divide the total volume of blood pumped per minute (L/min) by the number of beats per minute, you arrive at the **Mean Stroke Volume** (typically ~70 mL in a healthy adult). **2. Why the incorrect options are wrong:** * **A. Cardiac efficiency:** This refers to the ratio of external work performed by the heart to the total energy (oxygen) consumed. It is not a simple volume/rate calculation. * **C. Cardiac index:** This is the Cardiac Output adjusted for body surface area (CO / BSA). It relates heart performance to the size of the individual, not the heart rate. * **D. Mean arterial pressure (MAP):** This is the average pressure in the arteries during one cardiac cycle. It is calculated as: $MAP = Diastolic BP + 1/3 (Pulse Pressure)$ or $MAP = CO \times Total Peripheral Resistance$. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Normal Values:** Average CO is ~5 L/min; average SV is ~70 mL; average Cardiac Index is 2.5–4 L/min/m². * **Stroke Volume Determinants:** SV is influenced by **Preload** (End-diastolic volume), **Afterload** (Systemic vascular resistance), and **Inotropy** (Contractility). * **Ejection Fraction (EF):** A related high-yield concept; $EF = (Stroke Volume / End-Diastolic Volume) \times 100$. Normal EF is 55–70%. * **Fick’s Principle:** Remember that CO can also be calculated as: $Oxygen consumption / (Arterial O_2 content - Venous O_2 content)$.

Q: A 40-year-old man presents with a resting heart rate of 180 beats/min. A pressure-volume diagram of the left ventricle is shown below. What is the cardiac output?

5.6 L/min. ***5.6 L/min*** - **Cardiac output** = **Stroke Volume** × **Heart Rate**; from the PV loop, **stroke volume** ≈ 31 mL (EDV - ESV), so CO = 31 mL × 180 bpm = 5,580 mL/min ≈ **5.6 L/min**. - The **width of the PV loop** represents stroke volume, which appears reduced due to **tachycardia** limiting ventricular filling time. *5.2 L/min* - This would correspond to a **stroke volume** of approximately 29 mL (5,200 ÷ 180), which is lower than what the PV loop demonstrates. - The calculation underestimates the actual **stroke volume** visible in the pressure-volume diagram. *4.8 L/min* - This represents a **stroke volume** of approximately 27 mL (4,800 ÷ 180), significantly lower than the loop shows. - This would indicate **severe cardiac dysfunction** with markedly reduced contractility, not consistent with the PV loop morphology. *6 L/min* - This would require a **stroke volume** of approximately 33 mL (6,000 ÷ 180), which is higher than what the PV loop indicates. - The calculation overestimates the **end-diastolic volume minus end-systolic volume** difference shown in the diagram.

Q: Phase 1 of the myocardial action potential is primarily due to which ion movement?

Potassium efflux. **Explanation:** The myocardial action potential (specifically in non-pacemaker cells like ventricular myocytes) consists of five distinct phases (0 to 4). **Phase 1** is known as the **Initial Rapid Repolarization** phase. It occurs due to the inactivation of fast voltage-gated sodium channels and the simultaneous activation of **transient outward potassium currents ($I_{to}$)**. This results in a brief **efflux of Potassium ($K^+$) ions**, which causes the membrane potential to drop slightly toward 0 mV before the plateau phase begins. **Analysis of Options:** * **Option A (Correct):** Potassium efflux via $I_{to}$ channels is the primary ionic event responsible for the notch seen in the action potential curve during Phase 1. * **Option B (Incorrect):** While sodium channels do inactivate at the end of Phase 0, "blockage" is a pharmacological term (e.g., Class I antiarrhythmics) rather than the physiological mechanism of repolarization. * **Option C (Incorrect):** Calcium movement occurs primarily during Phase 2 (Plateau). Furthermore, Calcium moves **into** the cell (influx), not out (efflux), during this stage. **High-Yield NEET-PG Pearls:** * **Phase 0:** Rapid Depolarization ($Na^+$ influx). * **Phase 2 (Plateau):** Balance between $Ca^{2+}$ influx (L-type channels) and $K^+$ efflux. This phase is unique to cardiac muscle and prevents tetany. * **Phase 3:** Rapid Repolarization ($K^+$ efflux via delayed rectifier channels). * **Phase 4:** Resting Membrane Potential (maintained by $Na^+/K^+$ ATPase). * **Refractory Period:** The long plateau phase ensures the cardiac muscle has a long effective refractory period (ERP), allowing for proper ventricular filling.

Question 1

In which stage of red blood cell development does hemoglobin first appear?

Accepted Answer

Early normoblast

Answer

Intermediate normoblast

Answer

Late normoblast

Answer

Reticulocyte

Question 2

Which of the following is seen in second-degree AV block?

Accepted Answer

Change in morphology of ventricular complex

Answer

Increased atrial rate compared to ventricular rate

Answer

Increase in cardiac output

Answer

Decrease in stroke volume

Question 3

Which of the following phases is absent in the action potential of pacemaker cells?

Accepted Answer

Phase 1

Answer

Phase 0

Answer

Phase 3

Answer

Phase 4

Question 4

Triggered effect in myocardium is due to what?

Accepted Answer

Fat deposition

Answer

Malignant change

Answer

Seen in rheumatic fever

Answer

Associated with myocarditis

Question 5

Which peptide causes increased capillary permeability and edema?

Accepted Answer

Bradykinin

Answer

Histamine

Answer

Angiotensin II

Answer

Renin

Question 6

A patient's ECG shows Lead III with no S wave, but normal P, R, and T waves. What conclusions can be drawn about the patient's cardiac status?

Accepted Answer

No indications of cardiac abnormalities.

Answer

Abnormal activation of parts of the base of the heart.

Answer

Abnormal activation of parts of the apex of the heart.

Answer

Cardiac depression.

Question 7

What period does ventricular contraction correspond to on an ECG?

Accepted Answer

Beginning of Q wave to the end of T wave

Answer

Beginning of Q wave to end of S wave

Answer

Beginning of P wave to end of T wave

Answer

Beginning of R wave to the end of T wave, if Q wave is absent

Question 8

Cardiac output in L/min divided by heart rate equals:

Accepted Answer

Mean stroke volume

Answer

Cardiac efficiency

Answer

Cardiac index

Answer

Mean arterial pressure

Question 9

A 40-year-old man presents with a resting heart rate of 180 beats/min. A pressure-volume diagram of the left ventricle is shown below. What is the cardiac output?

Accepted Answer

5.6 L/min

Answer

5.2 L/min

Answer

4.8 L/min

Answer

6 L/min

Question 10

Phase 1 of the myocardial action potential is primarily due to which ion movement?

Accepted Answer

Potassium efflux

Answer

Sodium channel blockage

Answer

Calcium efflux

Answer

None of the above

Cardiovascular System — MCQs

Cardiovascular System — MCQs

On this page

Practice by Chapter

Want unlimited practice?